Clinical Research Directory
Browse clinical research sites, groups, and studies.
DRonabinol Treatment of OSA
Sponsor: VA Office of Research and Development
Summary
This is an open-label trial that tests the effectiveness of Dronabinol in treating obstructive sleep apnea (OSA). All participants will take oral Dronabinol for two weeks. Sleep studies will be conducted before and after treatment to measure OSA severity.
Official title: Targeted Treatment of Obstructive Sleep Apnea With Dronabinol: Proof of Concept and Phase II Clinical Trial
Key Details
Gender
All
Age Range
Any - 65 Years
Study Type
INTERVENTIONAL
Enrollment
120
Start Date
2025-08-25
Completion Date
2026-12-31
Last Updated
2025-09-12
Healthy Volunteers
No
Conditions
Interventions
Dronabinol
Open label Dronabinol treatment for two weeks.
Locations (1)
Jesse Brown VA Medical Center, Chicago, IL
Chicago, Illinois, United States